The National Academies Press

Currently Skimming:

Appendix A: Workshop Agenda
Pages 77-80

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.

From page 77... ... Anderson Cancer Center Technological Hurdles: vignettes 8:45 am Multiple Genetic Changes in Breast Cancer – Stephen Friend, Sage Bionetworks KRAS in Colorectal Cancer – Rafael Amado, GlaxoSmithKline EGFR in Lung Cancer – Bruce Johnson, Dana-Farber Cancer Institute FLT3 in Leukemia – Donald Small, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Pharmacogenomic Issues in Drug Development – Mark Ratain, University of Chicago Medical Center Moderator – Fred Appelbaum, Fred Hutchinson Cancer Research Center Read the entire page →
From page 78... ... Patient Perspective – Amy Bonoff, National Breast Cancer Coalition Moderator – Richard Schilsky, University of Chicago; Cancer and Leukemia Group B 12:45 pm LuNCH Regulatory Hurdles: Overview of Past Recommendations 1:45 pm The Original Secretary's Advisory Committee on Genetic Testing – Wylie Burke, University of Washington The Secretary's Advisory Committee on Genomics, Health and Society – Andrea Ferreira-Gonzalez, Virginia Commonwealth University Moderator – Steven Gutman, University of Central Florida bREAK 2:45 pm Regulatory Hurdles: What Is the Status Quo? 3:00 pm What Is the Food and Drug Administration Currently Doing? Read the entire page →
From page 79... ... – Debra Leonard, Weill Cornell Medical College Moderator – Steven Gutman, University of Central Florida 10:00 am bREAK 10:15 am Reimbursement Hurdles Medicare Coverage and Reimbursement – Jeffrey Roche, Coverage and Analysis Group, Centers for Medicare & Medicaid Services and Amy Bassano, Center for Medicare Management, Centers for Medicare & Medicaid Services Clinician Perspective – Daniel Hayes, University of Michigan Comprehensive Cancer Center Policy Perspective – Bruce Quinn, Foley Hoag, LLP Moderator – Peter Bach, Memorial Sloan-Kettering Cancer Center 12:15 pm bREAK – Please Retrieve Prepared Lunch and Return for Working Lunch with Last Session 12:30 pm Reactions to the Workshop Patient Perspective – Robert Erwin, Marti Nelson Cancer Foundation Industry Perspective – Stephen Friend, Merck & Co, Inc. and David Parkinson, Nodality, Inc. Read the entire page →

From page 77...

... Anderson Cancer Center Technological Hurdles: vignettes 8:45 am Multiple Genetic Changes in Breast Cancer – Stephen Friend, Sage Bionetworks KRAS in Colorectal Cancer – Rafael Amado, GlaxoSmithKline EGFR in Lung Cancer – Bruce Johnson, Dana-Farber Cancer Institute FLT3 in Leukemia – Donald Small, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Pharmacogenomic Issues in Drug Development – Mark Ratain, University of Chicago Medical Center Moderator – Fred Appelbaum, Fred Hutchinson Cancer Research Center

Read the entire page →

From page 78...

... Patient Perspective – Amy Bonoff, National Breast Cancer Coalition Moderator – Richard Schilsky, University of Chicago; Cancer and Leukemia Group B 12:45 pm LuNCH Regulatory Hurdles: Overview of Past Recommendations 1:45 pm The Original Secretary's Advisory Committee on Genetic Testing – Wylie Burke, University of Washington The Secretary's Advisory Committee on Genomics, Health and Society – Andrea Ferreira-Gonzalez, Virginia Commonwealth University Moderator – Steven Gutman, University of Central Florida bREAK 2:45 pm Regulatory Hurdles: What Is the Status Quo? 3:00 pm What Is the Food and Drug Administration Currently Doing?

Read the entire page →

From page 79...

... – Debra Leonard, Weill Cornell Medical College Moderator – Steven Gutman, University of Central Florida 10:00 am bREAK 10:15 am Reimbursement Hurdles Medicare Coverage and Reimbursement – Jeffrey Roche, Coverage and Analysis Group, Centers for Medicare & Medicaid Services and Amy Bassano, Center for Medicare Management, Centers for Medicare & Medicaid Services Clinician Perspective – Daniel Hayes, University of Michigan Comprehensive Cancer Center Policy Perspective – Bruce Quinn, Foley Hoag, LLP Moderator – Peter Bach, Memorial Sloan-Kettering Cancer Center 12:15 pm bREAK – Please Retrieve Prepared Lunch and Return for Working Lunch with Last Session 12:30 pm Reactions to the Workshop Patient Perspective – Robert Erwin, Marti Nelson Cancer Foundation Industry Perspective – Stephen Friend, Merck & Co, Inc. and David Parkinson, Nodality, Inc.

Read the entire page →

← Previous Chapter Skim

Next Chapter Skim →

This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.

Appendix A: Workshop Agenda Pages 77-80

Appendix A: Workshop Agenda
Pages 77-80